Displaying 841 - 860 of 9479
FTC Staff Provides Annual Letter to CFPB On 2022 Equal Credit Opportunity Act Activities
FTC Approves Final Orders against Google and iHeartMedia for Deceptive On-Air Endorsements for Google’s Pixel 4 Phone
New FTC Data Reveals Top Lies Told by Romance Scammers
Google LLC and iHeartMedia, Inc., In the Matter of
In November 2022, the FTC and seven state attorneys general sued Google LLC and iHeartMedia, Inc. for airing nearly 29,000 deceptive endorsements by radio personalities promoting their use of and experience with Google’s Pixel 4 phone in 2019 and 2020. The proposed FTC orders and the state judgments settling the allegations bar Google and iHeartMedia from similar misrepresentations, and the state judgments also require them to pay $9.4 million in penalties.
Epic Games, Inc., U.S. v.
FTC Order to Bar ZyCal Bioceuticals from Deceptive Health Marketing
ZyCal Bioceuticals Healthcare Company, Inc.
In February 2020, the FTC filed a complaint in federal district court against ZyCal Bioceuticals, a company that manufactured and sold the ingredient Cyplexinol to trade customers for use in making pain relief products for joint ailments, such as arthritis. Zycal also marketed a line of Cyplexinol-based pain relief products to chiropractors and directly to consumers under the brand name Ostinol. The same complaint includes allegations against another company, Excellent Marketing Results, Inc. (EMR), which was one of ZyCal's trade customers. EMR marketed a Cyplexinol-based formulation called StimTein via infomercials and online, and claimed it was clinically proven to stimulate cells to grow bone tissue and cartilage. EMR and its president agreed to a settlement that resolves charges against them in the FTC’s complaint, and prohibits them from making such health-related product claims unless they are supported by competent and reliable scientific evidence. In September 2020, the FTC announced it was returning more than $110,000 to consumers who bought EMR’s StimTein. In February 2023, the FTC announced a proposed order barring the ZyCal defendants from the deceptive conduct alleged in the complaint.
FTC Enforcement Action to Bar GoodRx from Sharing Consumers’ Sensitive Health Info for Advertising
FTC Commissioners Vote to Deny Motion by the Agency’s Staff Seeking Summary Decision Against Intuit
Federal Trade Commission Extends Public Comment Period on Potential Updates to its Green Guides for the Use of Environmental Marketing Claims
16 CFR Part 260: Guides for the Use of Environmental Marketing Claims: Extension of Comment Period
FTC Releases Reports on Cigarette and Smokeless Tobacco Sales and Marketing Expenditures for 2021
Federal Trade Commission Cigarette Report for 2021 and Smokeless Tobacco Report for 2021
FTC’s Bureau of Consumer Protection Issues Criminal Liaison Unit Report Detailing Efforts to Ensure Wrongdoers Face Accountability
FTC Finalizes Order with Ed Tech Provider Chegg for Lax Security that Exposed Student Data
Chegg
The FTC taking action against education technology provider Chegg Inc. for its lax data security practices that exposed sensitive information about millions of its customers and employees, including Social Security numbers, email addresses and passwords.
Displaying 841 - 860 of 9479